Approval · Notice of Compliance 37191 · 2026
BURINEX: Notice of Compliance 37191
Issued March 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37191
- Date
- March 25, 2026
- Company
- Karo Pharma AbStockholm, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BURINEX | Not yet assigned | — |
Medicinal ingredients
- BUMETANIDE 1 MG per TAB
- BUMETANIDE 5 MG per TAB